Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults

NCT04783311 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

279

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: EuCorVac-19
OTHER: Normal Saline

Sponsor

EuBiologics Co.,Ltd